The Medicinal Chemistry Collaborative team at UNCG

Newly discovered molecules that could prove to be anti-cancer agents.

Plant-derived compounds that could give us new ammunition against deadly drug-resistant bacteria such as MRSA.

Nanoparticles that might one day help doctors focus cancer drugs more precisely on tumors.

New drug candidates to minimize damage to the brain after a stroke.

That’s a small sample of the research that UNCG’s Medicinal Chemistry Collaborative– MC2 – is carrying out.

And there’s certainly more where that came from. That’s what happens when you combine a couple dozen chemists, biochemists, biologists and other scientists, plus their labs, students and millions of dollars in research grants, together in a single center.

Read More


Originally published January 3, 2018.


Accessibility options

Adjust the interface to make it easier to use for different conditions.
This renders the document in high contrast mode.
This renders the document as white on black
This can help those with trouble processing rapid screen movements.
This loads a font easier to read for people with dyslexia.